Skip to main content
Equibles

IFRX · InflaRx N.V. · Metrics

Track IFRX — free

Use IFRX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research IFRX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$1.55 +0.02 (+0.98%)
Rebalance outlook locked
Market Cap
$225.47M
Shares
147.37M
Volume · Oct 23 734.88K Avg daily vol (3M) 784.74K

IFRX metrics

47 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$1.53
Market cap
$225.47M

Price action

20 metrics
Price change (1W)
+6.3%
Price change (30D)
-26.4%
Price change (3M)
-11.6%
Price change (6M)
-1.9%
Price change (YTD)
+51.5%
Price change (1Y)
+20.5%
Trailing year
Price change (5Y)
-48.1%
52-week high
$2.74
52-week low
$0.83
Change from 52-week high
-44.2%
Change from 52-week low
+85.5%
Annualized volatility
96.6%
Annualized volatility (3M)
69.1%
Beta
2.4
RSI (14D)
39.9
Price vs SMA 50
-20.3%
Price vs SMA 200
-5.5%
Avg volume (3M)
784,742
Relative volume
0.5
Average dollar volume
$1.50M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
147.37M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
27.1
reciprocal yield 3.7%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
—

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
—

Profitability

9 metrics
Gross margin
-24,677.9%
Operating margin
—
Trailing 12 months
Net margin
-155,582.1%
Gross profit (TTM)
—
Operating profit (TTM)
—
Net income (TTM)
—
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$0.10

Growth

11 metrics
Revenue growth YoY
+520.3%
Year over year
Net income growth YoY
—
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+21.8%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-636.3%
Return on assets
-82.6%
Debt / equity
—
Current ratio
4.1
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
—
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$18.80M
Total assets
$64.80M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
—
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
62
13F filer change QoQ
+26
Institutional ownership
64.2%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+429.5%
Holder tenure
7.3
Price vs estimated holder cost
+9.4%

Ownership (registered funds)

1 metrics
Index-fund ownership
0.0%

Short interest

3 metrics
Short interest
8.4%
Latest settlement · 26.6 days to cover
Days to cover
26.6d
Short-squeeze score
72 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1708688 CUSIP N44821101 13F (30d) 5 filings 5 filers Visit website Investor relations